Human adipose tissue cannabinoid receptor 1 gene expression is not related to fat cell function or adiponectin level

被引:43
作者
Lofgren, Patrik [1 ]
Sjolin, Eva [1 ]
Wahlen, Kerstin [1 ]
Hoffstedt, Johan [1 ]
机构
[1] Karolinska Inst, Karolinska Univ Hosp, Dept Med, S-14186 Stockholm, Sweden
关键词
D O I
10.1210/jc.2006-2240
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The cannabinoid receptor 1 gene (CNR1) is implicated in adipocyte function. Objective: We investigated human adipose tissue CNR1 mRNA in relation to obesity, clinical and metabolic variables, adipocyte function, and adiponectin (ADIPOQ) levels. Methods: We assessed sc fat biopsies from 96 obese and nonobese subjects and omental fat biopsies from 82 obese and nonobese subjects. Results: The sc and omental adipose CNR1 gene expression were similar in obese and nonobese subjects. No association between either sc or omental adipose CNR1 mRNA levels and body mass index, waist circumference, plasma levels of glucose and insulin, lipids, or blood pressure was found. The sc and omental maximal adrenergic lipolytic activation as well as lipolytic adrenoceptor sensitivity were not related to CNR1 gene expression. Lipogenesis in sc adipocytes also showed no association with CNR1 mRNA levels. Finally, no relation was found between adipose CNR1 gene expression and ADIPOQ mRNA, adipose tissue adiponectin secretion, or circulating adiponectin. Conclusion: We found no association of human adipose tissue CNR1 mRNA expression with measures of body fat, metabolic parameters, fat cell function, or ADIPOQ expression. These data do not suggest a major role of human adipose CNR1 in fat cell function or metabolic disease development.
引用
收藏
页码:1555 / 1559
页数:5
相关论文
共 20 条
[1]  
ARNER P, 1987, AM J PHYSIOL, V253, P193
[2]   The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells [J].
Bensaid, M ;
Gary-Bobo, M ;
Esclangon, A ;
Maffrand, JP ;
Le Fur, G ;
Oury-Donat, F ;
Soubrié, P .
MOLECULAR PHARMACOLOGY, 2003, 63 (04) :908-914
[3]   Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity [J].
Blueher, Matthias ;
Engeli, Stefan ;
Kloeting, Nora ;
Berndt, Janin ;
Fasshauer, Mathias ;
Batkai, Sandor ;
Pacher, Pal ;
Schoen, Michael R. ;
Jordan, Jens ;
Stumvoll, Michael .
DIABETES, 2006, 55 (11) :3053-3060
[4]   EFFECTS OF INSULIN ON HUMAN ADIPOSE-TISSUE METABOLISM INVIVO [J].
COPPACK, SW ;
FRAYN, KN ;
HUMPHREYS, SM ;
DHAR, H ;
HOCKADAY, TDR .
CLINICAL SCIENCE, 1989, 77 (06) :663-670
[5]  
Cota D, 2003, J CLIN INVEST, V112, P423, DOI [10.1172/JCI200317725, 10.1172/JCI17725]
[6]   Contribution of CB1 blockade to the management of high-risk abdominal obesity [J].
Després, JP ;
Lemieux, I ;
Alméras, N .
INTERNATIONAL JOURNAL OF OBESITY, 2006, 30 (Suppl 1) :S44-S52
[7]   The endocannabinoid system and its therapeutic exploitation [J].
Di Marzo, V ;
Bifulco, M ;
De Petrocellis, L .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (09) :771-784
[8]   Activation of the peripheral endocannabinoid system in human obesity [J].
Engeli, S ;
Böhnke, J ;
Feldpausch, M ;
Gorzelniak, K ;
Janke, J ;
Bátkai, S ;
Pacher, P ;
Harvey-White, J ;
Luft, FC ;
Sharma, AM ;
Jordan, J .
DIABETES, 2005, 54 (10) :2838-2843
[9]   Evaluation of reference genes for studies of gene expression in human adipose tissue [J].
Gabrielsson, BG ;
Olofsson, LE ;
Sjögren, A ;
Jernås, M ;
Elander, A ;
Lönn, M ;
Rudemo, M ;
Carlsson, LMS .
OBESITY RESEARCH, 2005, 13 (04) :649-652
[10]   Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats [J].
Jamshidi, N ;
Taylor, DA .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (06) :1151-1154